Company Insights

FTLF customer relationships

FTLF customer relationship map

FitLife Brands (FTLF): customer relationships that shape revenue and risk

FitLife Brands sells proprietary and acquired nutritional supplements and wellness products primarily through retail partners and online channels; the company monetizes by manufacturing and selling finished goods to large national retailers and to consumers via ecommerce, capturing margin on branded SKUs and scaling through acquisitions and restored retail distribution. Revenue is concentrated in North America, with several large retail relationships driving a material share of sales while online marketplaces accelerate growth after recent acquisitions. For a focused map of FitLife's commercial footprint, see more at https://nullexposure.com/.

Business model and operating posture

  • FitLife operates as a seller of branded consumer packaged goods, transferring control of products at shipment and recognizing revenue on a spot-sales basis. The company’s commercial relationships are a mix of retail wholesale contracts and direct-to-consumer online sales, which shapes working capital and inventory dynamics.
  • Geographic concentration is high: the U.S. accounts for roughly 93–95% of sales, so macro retail trends and U.S. channel access determine near-term revenue sensitivity.
  • Customer concentration is meaningful: historically, GNC accounted for a large portion of sales (23% in 2024 and 33% in 2023), which the company describes as a material risk if that relationship weakens. At the same time, FitLife reports returns as immaterial, supporting a clean revenue recognition profile for spot sales.
  • Commercial maturity varies by channel: legacy retail listings through franchise distributors are stable and transactional, while marketplace channels (chiefly Amazon) are a growth lever that FitLife is actively investing in following recent acquisitions.

Key takeaways: spot-sales monetization, U.S.-centric revenue, and material exposure to major retail partners drive FitLife’s operating risk and upside.

The customer map — who buys FitLife products

GNC / General Nutrition Centers, Inc.

FitLife’s largest single customer historically is GNC: the company distributes NDS products principally through GNC’s franchised stores and centralized distribution, and management disclosed that sales to GNC’s platform accounted for approximately 23% of total sales in 2024 (down from 33% in 2023). According to FitLife’s filings and press releases, GNC is central to the wholesale channel and the company has repeatedly referenced the relationship in disclosures and acquisition announcements (FY2024 10‑K; GlobeNewswire 2022–2025 releases).

Vitamin Shoppe

Vitamin Shoppe is listed as a major iSatori customer and has been used as a pilot channel for MusclePharm Pro Series SKUs during retail rollouts; FitLife runs targeted, store-level pilots to restore or expand distribution with Vitamin Shoppe. This relationship is documented in the FY2024 Form 10‑K and in the company’s FY2025 investor communications (FitLife FY2024 10‑K; Q4 2024 results release, March 2025).

Walgreens

Walgreens is explicitly named among major customers of FitLife’s iSatori business unit, indicating placement in national drugstore chains as part of the company’s wholesale distribution strategy. The FY2024 Form 10‑K lists Walgreens alongside other major retail partners.

Amazon

FitLife is actively expanding its Amazon presence and has reported that Irwin Naturals product sales began on Amazon in October 2025; management also cites subscription discounting and advertising optimization on Amazon as an intentional growth channel, with recent comments indicating approximately $10,000 per day for newly listed products as of Q3 2025. These points are recorded in FitLife’s Q3 2025 results and related press releases (GlobeNewswire August and November 2025; QuiverQuant coverage of Q3 2025).

Walmart

Walmart appears as a prior distributor for acquired brands (for example, MusclePharm pre‑bankruptcy distribution included Walmart) and FitLife states an intent to restore distribution to large national retailers as part of integration and channel-restoration plans. The MusclePharm asset acquisition disclosure (September 2023) names Walmart among the prior retail partners.

Costco

Costco is referenced in FitLife’s commentary as a historical high-volume channel for acquired brands (Irwin and MusclePharm had meaningful Costco sales prior to bankruptcy or brand transition), and management notes efforts to reestablish those wholesale relationships during integration. The company cited Costco’s role in historical distribution in the MusclePharm acquisition announcement and reiterated the point during the Q3 2025 earnings call.

How these relationships translate into commercial strengths and risks

  • Concentration risk is real but actively managed. FitLife disclosed that GNC represented a material portion of sales in recent years, and management has publicly stated an intention to reduce that concentration through acquisitions and broader retail and online distribution. This is a company-level signal supported by multiple press releases (GlobeNewswire 2022; Q4 2024 results).
  • Contracting posture is transactional. Revenue recognition language indicates control transfers at shipment and performance obligations are satisfied on delivery, consistent with spot-sale commercial terms rather than long-term take-or-pay contracts.
  • Channel mix drives margin variability. Wholesale placements with large retailers provide predictable reorder patterns but create concentration; Amazon and direct ecommerce present margin expansion opportunities, but they require ongoing advertising investment and assortment management.
  • Geographic concentration amplifies retail-cycle exposure. With roughly 93–95% of sales in North America, U.S. retail channel health and shelf-placement decisions have outsize impact on FitLife’s top line.

A short risk matrix for investors

  • High: retailer concentration (GNC) — material revenue share historically documented in filings.
  • Medium: channel execution on Amazon — early traction reported post‑acquisition but requires sustained marketing and listing optimization.
  • Low-to-medium: return and recognition risk — the company reports product returns as immaterial, supporting revenue stability.

Want a deeper look at FitLife’s counterparty relationships and the documents behind these summaries? Explore the full relationships map and filings at https://nullexposure.com/.

Final recommendation and next steps For investors and operators evaluating FitLife, the focus is clear: assess progress in de‑concentrating revenue away from GNC, monitor Amazon marketplace economics post‑acquisition, and track restoration of big‑box and specialty retail listings (Costco, Walmart, Vitamin Shoppe, Walgreens). These are the vectors that will determine whether growth from recent acquisitions converts into durable margin expansion or simply shifts channel risk.

To inspect filings and the relationship inventory underpinning this overview, visit https://nullexposure.com/ for the original sources and document references. For engagement on commercial due diligence or to request a tailored relationship analysis, return to https://nullexposure.com/ and request bespoke coverage.